Lars Gerdes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lars Gerdes has a total of 106 co-authors. Here are the top co-authors by number of shared publications:
Jürgen Soll
3 shared publications- Sven Pecoraro
Bavarian Health and Food Safety Authority (LGL), Oberschleißheim, Germany
3 shared publications Ulrich Busch
Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit (LGL), Oberschleissheim, Germany
3 shared publicationsAzuka Iwobi
Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit (LGL), Oberschleissheim, Germany
2 shared publicationsIngrid Huber
Bavarian Health and Food Safety Authority (LGL), Veterinärstr. 2, 85764, Oberschleißheim, Germany
2 shared publications- Jens Frederik Dahlerup
Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark
2 shared publications
Latest Publications
- 1 May 2021
- Published by Elsevier in Food Control
- Vol. 123, 107764
Food fraud in the Alps? — Detection of chamois (Rupicapra rupicapra) in firm raw sausages, ham, and meat via qualitative duplex real-time PCR
- 1 May 2021
- Published by Elsevier in Food Control
- Vol. 123, 107764
Food fraud in the Alps? — Detection of chamois (Rupicapra rupicapra) in firm raw sausages, ham, and meat via qualitative duplex real-time PCR
- Open Access
- 25 October 2017
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 410 (1) , 211-221
Inter-laboratory analysis of selected genetically modified plant reference materials with digital PCR
Digital PCR (dPCR), as a new technology in the field of genetically modified (GM) organism (GMO) testing, enables determination of absolute target copy numbers. The purpose of our study was to test the transferability of methods designed for quantitative PCR (qPCR) to dPCR and to carry out an inter-laboratory comparison of the performance of two different dPCR platforms when determining the absolute GM copy numbers and GM copy number ratio in reference materials certified for GM content in mass fraction. Overall results in terms of measured GM% were within acceptable variation limits for both tested dPCR systems. However, the determined absolute copy numbers for individual genes or events showed higher variability between laboratories in one third of the cases, most possibly due to variability in the technical work, droplet size variability, and analysis of the raw data. GMO quantification with dPCR and qPCR was comparable. As methods originally designed for qPCR performed well in dPCR systems, already validated qPCR assays can most generally be used for dPCR technology with the purpose of GMO detection.
- 25 October 2017
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 410 (1) , 211-221
Open AccessInter-laboratory analysis of selected genetically modified plant reference materials with digital PCR
Digital PCR (dPCR), as a new technology in the field of genetically modified (GM) organism (GMO) testing, enables determination of absolute target copy numbers. The purpose of our study was to test the transferability of methods designed for quantitative PCR (qPCR) to dPCR and to carry out an inter-laboratory comparison of the performance of two different dPCR platforms when determining the absolute GM copy numbers and GM copy number ratio in reference materials certified for GM content in mass fraction. Overall results in terms of measured GM% were within acceptable variation limits for both tested dPCR systems. However, the determined absolute copy numbers for individual genes or events showed higher variability between laboratories in one third of the cases, most possibly due to variability in the technical work, droplet size variability, and analysis of the raw data. GMO quantification with dPCR and qPCR was comparable. As methods originally designed for qPCR performed well in dPCR systems, already validated qPCR assays can most generally be used for dPCR technology with the purpose of GMO detection.
- Open Access
- 31 May 2017
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 11 (10) , 1213-1222
Occurrence of Anaemia in the First Year of Inflammatory Bowel Disease in a European Population-based Inception Cohort—An ECCO-EpiCom Study
Anaemia is an important complication of inflammatory bowel disease [IBD]. The aim of this study was to determine the prevalence of anaemia and the practice of anaemia screening during the first year following diagnosis, in a European prospective population-based inception cohort. Newly diagnosed IBD patients were included and followed prospectively for 1 year in 29 European and one Australian centre. Clinical data including demographics, medical therapy, surgery and blood samples were collected. Anaemia was defined according to the World Health Organization criteria. A total of 1871 patients (Crohn’s disease [CD]: 686, 88%; ulcerative colitis [UC]: 1,021, 87%; IBD unclassified [IBDU] 164. 81%) were included in the study. The prevalence of anaemia was higher in CD than in UC patients and, overall, 49% of CD and 39% of UC patients experienced at least one instance of anaemia during the first 12 months after diagnosis. UC patients with more extensive disease and those from Eastern European countries, and CD patients with penetrating disease or colonic disease location, had higher risks of anaemia. CD and UC patients in need of none or only mild anti-inflammatory treatment had a lower risk of anaemia. In a significant proportion of patients, anaemia was not assessed until several months after diagnosis, and in almost half of all cases of anaemia a thorough work-up was not performed. Overall, 42% of patients had at least one instance of anaemia during the first year following diagnosis. Most patients were assessed for anaemia regularly; however, a full anaemia work-up was frequently neglected in this community setting.
- 31 May 2017
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 11 (10) , 1213-1222
Open AccessOccurrence of Anaemia in the First Year of Inflammatory Bowel Disease in a European Population-based Inception Cohort—An ECCO-EpiCom Study
Anaemia is an important complication of inflammatory bowel disease [IBD]. The aim of this study was to determine the prevalence of anaemia and the practice of anaemia screening during the first year following diagnosis, in a European prospective population-based inception cohort. Newly diagnosed IBD patients were included and followed prospectively for 1 year in 29 European and one Australian centre. Clinical data including demographics, medical therapy, surgery and blood samples were collected. Anaemia was defined according to the World Health Organization criteria. A total of 1871 patients (Crohn’s disease [CD]: 686, 88%; ulcerative colitis [UC]: 1,021, 87%; IBD unclassified [IBDU] 164. 81%) were included in the study. The prevalence of anaemia was higher in CD than in UC patients and, overall, 49% of CD and 39% of UC patients experienced at least one instance of anaemia during the first 12 months after diagnosis. UC patients with more extensive disease and those from Eastern European countries, and CD patients with penetrating disease or colonic disease location, had higher risks of anaemia. CD and UC patients in need of none or only mild anti-inflammatory treatment had a lower risk of anaemia. In a significant proportion of patients, anaemia was not assessed until several months after diagnosis, and in almost half of all cases of anaemia a thorough work-up was not performed. Overall, 42% of patients had at least one instance of anaemia during the first year following diagnosis. Most patients were assessed for anaemia regularly; however, a full anaemia work-up was frequently neglected in this community setting.
- 1 April 2017
- Published by Elsevier in Food Control
- Vol. 74, 89-97
A multiplex real-time PCR method for the quantitative determination of equine (horse) fractions in meat products
- 1 April 2017
- Published by Elsevier in Food Control
- Vol. 74, 89-97
A multiplex real-time PCR method for the quantitative determination of equine (horse) fractions in meat products
- 10 January 2017
- Published by Springer Nature in Journal of Consumer Protection and Food Safety
- Vol. 12 (S1) , 53-56
Digitale PCR
- 10 January 2017
- Published by Springer Nature in Journal of Consumer Protection and Food Safety
- Vol. 12 (S1) , 53-56
Digitale PCR
- 1 November 2016
- Published by Elsevier in Food Control
- Vol. 69, 205-213
Droplet digital PCR for routine analysis of genetically modified foods (GMO) – A comparison with real-time quantitative PCR
- 1 November 2016
- Published by Elsevier in Food Control
- Vol. 69, 205-213
Droplet digital PCR for routine analysis of genetically modified foods (GMO) – A comparison with real-time quantitative PCR
- Open Access
- 1 March 2016
- Published by Elsevier in Biomolecular Detection and Quantification
- Vol. 7, 9-20
Optimization of digital droplet polymerase chain reaction for quantification of genetically modified organisms
- 1 March 2016
- Published by Elsevier in Biomolecular Detection and Quantification
- Vol. 7, 9-20
Open AccessOptimization of digital droplet polymerase chain reaction for quantification of genetically modified organisms
- Open Access
- 14 December 2014
- Published by Springer Nature in BMC Bioinformatics
- Vol. 15 (1) , 407
A statistical approach to quantification of genetically modified organisms (GMO) using frequency distributions
According to Regulation (EU) No 619/2011, trace amounts of non-authorised genetically modified organisms (GMO) in feed are tolerated within the EU if certain prerequisites are met. Tolerable traces must not exceed the so-called ‘minimum required performance limit’ (MRPL), which was defined according to the mentioned regulation to correspond to 0.1% mass fraction per ingredient. Therefore, not yet authorised GMO (and some GMO whose approvals have expired) have to be quantified at very low level following the qualitative detection in genomic DNA extracted from feed samples. As the results of quantitative analysis can imply severe legal and financial consequences for producers or distributors of feed, the quantification results need to be utterly reliable. We developed a statistical approach to investigate the experimental measurement variability within one 96-well PCR plate. This approach visualises the frequency distribution as zygosity-corrected relative content of genetically modified material resulting from different combinations of transgene and reference gene Cq values. One application of it is the simulation of the consequences of varying parameters on measurement results. Parameters could be for example replicate numbers or baseline and threshold settings, measurement results could be for example median (class) and relative standard deviation (RSD). All calculations can be done using the built-in functions of Excel without any need for programming. The developed Excel spreadsheets are available (see section ‘Availability of supporting data’ for details). In most cases, the combination of four PCR replicates for each of the two DNA isolations already resulted in a relative standard deviation of 15% or less. The aims of the study are scientifically based suggestions for minimisation of uncertainty of measurement especially in —but not limited to— the field of GMO quantification at low concentration levels. Four PCR replicates for each of the two DNA isolations seem to be a reasonable minimum number to narrow down the possible spread of results.
- 14 December 2014
- Published by Springer Nature in BMC Bioinformatics
- Vol. 15 (1) , 407
Open AccessA statistical approach to quantification of genetically modified organisms (GMO) using frequency distributions
According to Regulation (EU) No 619/2011, trace amounts of non-authorised genetically modified organisms (GMO) in feed are tolerated within the EU if certain prerequisites are met. Tolerable traces must not exceed the so-called ‘minimum required performance limit’ (MRPL), which was defined according to the mentioned regulation to correspond to 0.1% mass fraction per ingredient. Therefore, not yet authorised GMO (and some GMO whose approvals have expired) have to be quantified at very low level following the qualitative detection in genomic DNA extracted from feed samples. As the results of quantitative analysis can imply severe legal and financial consequences for producers or distributors of feed, the quantification results need to be utterly reliable. We developed a statistical approach to investigate the experimental measurement variability within one 96-well PCR plate. This approach visualises the frequency distribution as zygosity-corrected relative content of genetically modified material resulting from different combinations of transgene and reference gene Cq values. One application of it is the simulation of the consequences of varying parameters on measurement results. Parameters could be for example replicate numbers or baseline and threshold settings, measurement results could be for example median (class) and relative standard deviation (RSD). All calculations can be done using the built-in functions of Excel without any need for programming. The developed Excel spreadsheets are available (see section ‘Availability of supporting data’ for details). In most cases, the combination of four PCR replicates for each of the two DNA isolations already resulted in a relative standard deviation of 15% or less. The aims of the study are scientifically based suggestions for minimisation of uncertainty of measurement especially in —but not limited to— the field of GMO quantification at low concentration levels. Four PCR replicates for each of the two DNA isolations seem to be a reasonable minimum number to narrow down the possible spread of results.
- 30 September 2014
- Published by Springer Nature in BIOspektrum
- Vol. 20 (6) , 632-635
Digitale Polymerasekettenreaktion (dPCR)
- 30 September 2014
- Published by Springer Nature in BIOspektrum
- Vol. 20 (6) , 632-635
Digitale Polymerasekettenreaktion (dPCR)
- 2 December 2011
- Published by Springer Nature in European Food Research and Technology
- Vol. 234 (2) , 315-322
Parallelised real-time PCR for identification of maize GMO events
- 2 December 2011
- Published by Springer Nature in European Food Research and Technology
- Vol. 234 (2) , 315-322
Parallelised real-time PCR for identification of maize GMO events